[1]
|
彭华红, 肖龙飞, 王林, 等. ARL4C在睾丸生殖细胞肿瘤中的表达及临床意义[J]. 天津医科大学学报, 2020, 26(3): 238-243.
|
[2]
|
Katabathina, V.S., Vargas-Zapata, D., Monge, R.A., et al. (2021) Testicular Germ Cell Tumors: Classification, Pathologic Features, Imaging Findings, and Management. RadioGraphics, 41, 1698-1716.
https://doi.org/10.1148/rg.2021210024
|
[3]
|
Znaor, A., Skakkebaek, N.E., Rajpert-De Meyts, E., et al. (2020) Tes-ticular Cancer Incidence Predictions in Europe 2010-2035: A Rising Burden despite Population Ageing. International Journal of Cancer, 147, 820-828.
https://doi.org/10.1002/ijc.32810
|
[4]
|
Sung, H., Ferlay, J., Siegel, R.L., et al. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249.
https://doi.org/10.3322/caac.21660
|
[5]
|
李路, 李家贵. 原发性睾丸肿瘤研究新进展[J]. 现代泌尿生殖肿瘤杂志, 2009, 1(6): 321-324.
|
[6]
|
Nettersheim, D. and Albers, P. (2022) Special Issue on Testis Cancer. World Journal of Urology, 40, 305-306.
https://doi.org/10.1007/s00345-022-03957-w
|
[7]
|
Harries, L.W. (2019) RNA Biology Provides New Therapeutic Targets for Human Disease. Frontiers in Genetics, 10, Article No. 205. https://doi.org/10.3389/fgene.2019.00205
|
[8]
|
Cortez, M.A., Bueso-Ramos, C., Ferdin, J., et al. (2011) Mi-croRNAs in Body Fluids—The Mix of Hormones and Biomarkers. Nature Reviews Clinical Oncology, 8, 467-477. https://doi.org/10.1038/nrclinonc.2011.76
|
[9]
|
Zamore, P.D. and Haley, B. (2005) Ribo-Gnome: The Big World of Small RNAs. Science, 309, 1519-1524.
https://doi.org/10.1126/science.1111444
|
[10]
|
Hong, S.H., Kwon, J.T., Kim, J., et al. (2018) Profiling of Tes-tis-Specific Long Noncoding RNAs in Mice. BMC Genomics, 19, Article No. 539. https://doi.org/10.1186/s12864-018-4931-3
|
[11]
|
Eini, R., Dorssers, L.C. and Looijenga, L.H. (2013) Role of Stem Cell Proteins and microRNAs in Embryogenesis and Germ Cell Cancer. The International Journal of Developmental Bi-ology, 57, 319-332.
https://doi.org/10.1387/ijdb.130020re
|
[12]
|
Syring, I., Bartels, J., Holdenrieder, S., et al. (2015) Circulating Serum miRNA (miR-367-3p, miR-371a-3p, miR- 372-3p and miR-373-3p) as Biomarkers in Patients with Testicular Germ Cell Cancer. Journal of Urology, 193, 331-337.
https://doi.org/10.1016/j.juro.2014.07.010
|
[13]
|
Belge, G., Hennig, F., Dumlupinar, C., et al. (2020) Graded Ex-pression of microRNA-371a-3p in Tumor Tissues, Contralateral Testes, and in Serum of Patients with Testicular Germ Cell Tumor. Oncotarget, 11, 1462-1473.
https://doi.org/10.18632/oncotarget.27565
|
[14]
|
Spiekermann, M., Belge, G., Winter, N., et al. (2015) MicroRNA miR-371a-3p in Serum of Patients with Germ Cell Tumours: Evaluations for Establishing a Serum Biomarker. Andrology, 3, 78-84.
https://doi.org/10.1111/j.2047-2927.2014.00269.x
|
[15]
|
Vilela-Salgueiro, B., Barros-Silva, D., Lobo, J., et al. (2018) Germ Cell Tumour Subtypes Display Differential Expression of microRNA371a-3p. Philosophical Transactions of the Royal Society B: Biological Sciences, 373, Article ID: 20170338. https://doi.org/10.1098/rstb.2017.0338
|
[16]
|
Salvatori, D.C.F., Dorssers, L.C.J., Gillis, A.J.M., et al. (2018) The microRNA-371 Family as Plasma Biomarkers for Monitoring Undifferentiated and Potentially Malignant Human Plu-ripotent Stem Cells in Teratoma Assays. Stem Cell Reports, 11, 1493-1505. https://doi.org/10.1016/j.stemcr.2018.11.002
|
[17]
|
Dieckmann, K.P., Radtke, A., Spiekermann, M., et al. (2017) Serum Levels of MicroRNA miR-371a-3p: A Sensitive and Specific New Biomarker for Germ Cell Tumours. European Urology, 71, 213-220.
https://doi.org/10.1016/j.eururo.2016.07.029
|
[18]
|
Palmer, R.D., Murray, M.J., Saini, H.K., et al. (2010) Malignant Germ Cell Tumors Display Common microRNA Profiles Resulting in Global Changes in Expression of Messenger RNA Targets. Cancer Research, 70, 2911-2923.
https://doi.org/10.1158/0008-5472.CAN-09-3301
|
[19]
|
Belge, G., Dieckmann, K.P., Spiekermann, M., et al. (2012) Serum Levels of microRNAs miR-371-3: A Novel Class of Serum Biomarkers for Testicular Germ Cell Tumors? Euro-pean Urology, 61, 1068-1069.
https://doi.org/10.1016/j.eururo.2012.02.037
|
[20]
|
Dieckmann, K.P., Spiekermann, M., Balks, T., et al. (2012) Mi-croRNAs miR-371-3 in Serum as Diagnostic Tools in the Management of Testicular Germ Cell Tumours. British Journal of Cancer, 107, 1754-1760.
https://doi.org/10.1038/bjc.2012.469
|
[21]
|
Bezan, A., Gerger, A. and Pichler, M. (2014) MicroRNAs in Testicular Cancer: Implications for Pathogenesis, Diagnosis, Prognosis and Therapy. AntiCancer Research, 34, 2709-2713.
|
[22]
|
Sanders, I., Holdenrieder, S., Walgenbach-Brünagel, G., et al. (2012) Evaluation of Reference Genes for the Analysis of Serum miRNA in Patients with Prostate Cancer, Bladder Cancer and Renal Cell Carcinoma. Interna-tional Journal of Urology, 19, 1017-1025. https://doi.org/10.1111/j.1442-2042.2012.03082.x
|
[23]
|
Gillis, A.J., Stoop, H.J., Hersmus, R., et al. (2007) High-Throughput microRNAome Analysis in Human Germ Cell Tumours. The Journal of Pathology, 213, 319-328. https://doi.org/10.1002/path.2230
|
[24]
|
Bing, Z., Master, S.R., Tobias, J.W., et al. (2012) MicroRNA Expression Profiles of Seminoma from Paraffin-Embedded Formalin-Fixed Tissue. Virchows Ar-chiv, 461, 663-668. https://doi.org/10.1007/s00428-012-1325-9
|
[25]
|
Lobo, J., Gillis, A.J.M., Jerónimo, C., et al. (2019) Human Germ Cell Tumors Are Developmental Cancers: Impact of Epigenetics on Pathobiology and Clinic. In-ternational Journal of Molecular Sciences, 20, Article No. 258.
https://doi.org/10.3390/ijms20020258
|
[26]
|
Mego, M., van Agthoven, T., Gronesova, P., et al. (2019) Clinical Util-ity of Plasma miR-371a-3p in Germ Cell Tumors. Journal of Cellular and Molecular Medicine, 23, 1128-1136. https://doi.org/10.1111/jcmm.14013
|
[27]
|
Badia, R.R., Abe, D., Wong, D., et al. (2021) Real-World Application of Pre-Orchiectomy miR-371a-3p Test in Testicular Germ Cell Tumor Management. Journal of Urology, 205, 137-144.
https://doi.org/10.1097/JU.0000000000001337
|
[28]
|
Bagrodia, A., Savelyeva, A., Lafin, J.T., et al. (2021) Impact of Circulating microRNA Test (miRNA-371a-3p) on Appropriateness of Treatment and Cost Outcomes in Patients with Stage I Non-Seminomatous Germ Cell Tumours. BJU International, 128, 57-64. https://doi.org/10.1111/bju.15288
|
[29]
|
Charytonowicz, D., Aubrey, H., Bell, C., et al. (2019) Cost Analysis of Noninvasive Blood-Based microRNA Testing versus CT Scans for Follow-Up in Patients with Testicular Germ-Cell Tumors. Clinical Genitourinary Cancer, 17, e733-e744. https://doi.org/10.1016/j.clgc.2019.03.015
|
[30]
|
van Ag-thoven, T., Eijkenboom, W.M.H. and Looijenga, L.H.J. (2017) microRNA-371a-3p as Informative Biomarker for the Follow-Up of Testicular Germ Cell Cancer Patients. Cellular Oncology (Dordr), 40, 379-388.
https://doi.org/10.1007/s13402-017-0333-9
|
[31]
|
Gilligan, T.D., Seidenfeld, J., Basch, E.M., et al. (2010) American Society of Clinical Oncology Clinical Practice Guideline on Uses of Serum Tumor Markers in Adult Males with Germ Cell Tumors. Journal of Clinical Oncology, 28, 3388-3404. https://doi.org/10.1200/JCO.2009.26.4481
|
[32]
|
Ehrlich, Y., Beck, S.D., Foster, R.S., et al. (2013) Serum Tumor Markers in Testicular Cancer. Urologic Oncology, 31, 17-23. https://doi.org/10.1016/j.urolonc.2010.04.007
|